化合物GSK503 T1775
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
500 mg | 1346572-63-1 | ¥10,600.00 | 询底价 |
1 mL | 1346572-63-1 | ¥859.00 | 询底价 |
5 mg | 1346572-63-1 | ¥745.00 | 询底价 |
25 mg | 1346572-63-1 | ¥2,270.00 | 询底价 |
50 mg | 1346572-63-1 | ¥3,480.00 | 询底价 |
1 mg | 1346572-63-1 | ¥315.00 | 询底价 |
10 mg | 1346572-63-1 | ¥1,160.00 | 询底价 |
2 mg | 1346572-63-1 | ¥453.00 | 询底价 |
100 mg | 1346572-63-1 | ¥4,930.00 | 询底价 |
Product Introduction
Bioactivity
英文名: GSK503
描述: GSK503是一种高效特异性EZH2甲基转移酶抑制剂,Ki 值为3到27 nM,具有潜在的抗肿瘤活性。
激酶实验: In vitro biochemical assays against histone acetylases: GSK503 is profiled to assess inhibition against a panel of histone acetylases. GSK503 is dissolved in DMSO and tested in 10-dose IC50 mode with 3-fold serial dilution starting at 100 μM, with a final DMSO concentration of 2%. Anacardic Acid is used as positive control for CBP, GCN5, and pCAF and tested in 10-dose IC50 mode with 3-fold serial dilution starting at 100 μM. Curcumin is used as positive control for KAT5, MYST2/KAT7, MYST4/KAT6B, and p300, and tested in 10-dose IC50 mode with 3-fold serial dilution starting at 100 μM. Reactions are carried out at 3.08 μM Acetyl-CoA. For CBP, GCN5, MYST2/KAT7, pCAF, and p300, the substrate used is histone H3. For KAT5 and MYST4/KAT6B the substrates used are histone H2A and histone H4, respectively.
体外活性: GSK503能够以相近的效力抑制WT和突变型EZH2的甲基转移酶活性。在七种DLBCL细胞系的研究中,GSK503显示出对细胞生长的抑制作用,并且这种效果在与ABT737或Obatoclax联用时得到增强。[1]
体内活性: In C57BL6 mice immunized with SRBC, GSK503 (150 mg/kg, i.p.) reduced the level of H3K27me3 in splenocytes. In male SCID mice bearing SUDHL4 and SUDHL6 tumors, GSK503 (150 mg/kg, i.p.) inhibits tumor growth. [1] In C57Bl/6 mice bearing murine B16-F10 tumors, GSK503 (150 mg/kg, i.p.) significantly reduces global H3K27me3 levels, inhibits tumor growth and virtually abolishes metastases formation. [2]
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 93 mg/mL (176.6 mM)
Ethanol : 25 mg/mL (47.5 mM)
H2O : < 1 mg/mL (insoluble or slightly soluble)
关键字: GSK503 | Inhibitor | inhibit | GSK-503 | GSK 503 | Histone Methyltransferase
相关产品: CPI-169 racemate | MS023 trihydrochloride | BMS-911543 | SNDX-5613 | Antitumor agent-101 | MS0124 | VTP50469 | Cyproheptadine hydrochloride sesquihydrate | MI-538 | BIX-01294
相关库: Anti-Aging Compound Library | Inhibitor Library | Epigenetics Compound Library | Anti-Cancer Active Compound Library | Target-Focused Phenotypic Screening Library | Methylation Compound Library | Reprogramming Compound Library | NO PAINS Compound Library | Bioactive Compound Library | Chromatin Modification Compound Library
化合物GSK503 T1775信息由TargetMol中国为您提供,如您想了解更多关于化合物GSK503 T1775报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途